Composition Each vial is represented as an 80mg blend: 50mg GHK-Cu, 10mg KPV, 10mg TB-500, and 10mg BPC-157
9 Many of these patients are currently using or will eventually use GLP-1 RAs
They are not approved for human or veterinary use
BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)
Water Retention : Increased GH levels can sometimes lead to mild water retention, particularly in the first few weeks of treatment
Either a differentiated formulation, like compounded generic semaglutide with B12 or whatever else, or a high-touch service layer thatll keep patients on the platform